4d pharma PLC (LSE:DDDD) - Share price


Stock Report

4d pharma PLC DDDD

Last Price
GBX99.80

Day Change
3.00|3.10%

As of 27/11/2020
17:13:32 GMT | GBX
Minimum 15 Minutes Delay.

Last Close96.80p
Day Range95.20 - 105.08
Mkt Cap131.10Mil
52-Wk Range23.50 - 183.00
Yield %-
ISINGB00BJL5BR07
Volume3,421,782
P/E-
P/S3.10
P/CF-0.03

Share Price

Total Returns 27/11/2020

 Chg (%)  
More ...
4d pharma PLC-13.97 
FTSE 100 TR GBP11.51
 
Financials
201720182019
More ...
Income Statement
Turnover-0.000.21
Operating Profit-20.36-29.12-30.61
Net Profit-20.45-23.69-24.07
Reported EPS-31.41-36.17-36.75
Balance Sheet
Current Assets57.8033.1611.27
Non Current Assets19.9419.4519.34
Total Assets77.7452.6130.61
Current Liabilities4.985.186.26
Total Liabilities---
Total Equity69.7945.7622.34
Cash Flow
Operating Cash Flow-17.19-22.94-21.56
Net Change in Cash-16.804.19-12.22
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
16/07/2020PurchaseDr. Alexander James Stevenson35.00571,428200,000.00
16/07/2020PurchaseDavid Robert Norwood35.00285,714100,000.00
16/07/2020PurchaseDuncan Joseph Peyton35.00571,428200,000.00
16/07/2020PurchaseProfessor Axel Gaston Glasmacher35.0030,00010,500.00

Company Profile

4d pharma PLC through its subsidiaries is involved in the business of research and development and manufacturing of live biotherapeutic products for the diseases such as cancer, asthma, autism, arthritis and multiple scelerosis.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 26/05/2021

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-118.74
Op Mrgn-145.09
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Scientific OfficerDr. Alexander James Stevenson
Executive Director, Chief Executive OfficerDuncan Joseph Peyton
Non-Executive Director, ChairmanProfessor Axel Gaston Glasmacher
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.